JP2003501081A - 幹細胞の増殖工程 - Google Patents

幹細胞の増殖工程

Info

Publication number
JP2003501081A
JP2003501081A JP2001502556A JP2001502556A JP2003501081A JP 2003501081 A JP2003501081 A JP 2003501081A JP 2001502556 A JP2001502556 A JP 2001502556A JP 2001502556 A JP2001502556 A JP 2001502556A JP 2003501081 A JP2003501081 A JP 2003501081A
Authority
JP
Japan
Prior art keywords
stem cells
cell
cells
inhibitor
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501081A5 (https=
Inventor
アトフェルド，ジャック・アレクサンドル
アトフェルド，アントワネット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of JP2003501081A publication Critical patent/JP2003501081A/ja
Publication of JP2003501081A5 publication Critical patent/JP2003501081A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2001502556A 1999-06-03 2000-05-30 幹細胞の増殖工程 Pending JP2003501081A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/07011 1999-06-03
FR9907011A FR2794473B1 (fr) 1999-06-03 1999-06-03 Procede de multiplication de cellules souches
PCT/FR2000/001486 WO2000075290A1 (fr) 1999-06-03 2000-05-30 Procede de multiplication de cellules souches

Publications (2)

Publication Number Publication Date
JP2003501081A true JP2003501081A (ja) 2003-01-14
JP2003501081A5 JP2003501081A5 (https=) 2007-06-14

Family

ID=9546326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502556A Pending JP2003501081A (ja) 1999-06-03 2000-05-30 幹細胞の増殖工程

Country Status (6)

Country Link
US (2) US7601534B1 (https=)
EP (1) EP1181354A1 (https=)
JP (1) JP2003501081A (https=)
CA (1) CA2375485A1 (https=)
FR (1) FR2794473B1 (https=)
WO (1) WO2000075290A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515818A (ja) * 2004-10-07 2008-05-15 ステム セル セラピューティクス コーポレイション 妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激
WO2012133156A1 (ja) 2011-03-25 2012-10-04 国立大学法人京都大学 上皮系体性幹細胞の製造方法
JP2014516562A (ja) * 2011-06-10 2014-07-17 コーニンクレッカ ネザーランド アカデミー ヴァン ウェテンシャッペン 幹細胞のための培養培地

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077404A1 (en) 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
KR20080103108A (ko) * 2006-03-17 2008-11-26 스템 셀 테라퓨틱스 코포레이션 신경 장애 치료를 위한 ｌｈ 또는 ｈｃｇ 및 ｅｐｏ의 투여방법
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
ES2579909T3 (es) 2009-02-03 2016-08-17 Koninklijke Nederlandse Akademie Van Wetenschappen Medio de cultivo para células madre epiteliales y organoides que comprenden dichas células madre
WO2011069091A1 (en) 2009-12-04 2011-06-09 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
US9164079B2 (en) * 2011-03-17 2015-10-20 Greyledge Technologies Llc Systems for autologous biological therapeutics
GB201721615D0 (en) 2017-12-21 2018-02-07 Koninklijke Nederlandse Akademie Van Wetenschappen Immune cell organoid co-cultures
WO2024259127A2 (en) * 2023-06-13 2024-12-19 The Children's Medical Center Corporation Methods for generating human amniotic membrane and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000777A1 (de) * 1994-06-30 1996-01-11 Boehringer Ingelheim International Gmbh Verfahren zur herstellung und züchtung hämatopoetischer vorläuferzellen
JPH08205860A (ja) * 1994-01-21 1996-08-13 Usa Government 造血細胞の膨大化および移植方法
WO1997033978A1 (en) * 1996-03-12 1997-09-18 Life Technologies, Inc. Hematopoietic cell culture nutrient supplement
WO1998013475A1 (en) * 1996-09-25 1998-04-02 Academisch Ziekenhuis Leiden Methods for culturing cells
JPH10136978A (ja) * 1996-11-08 1998-05-26 Otsuka Pharmaceut Co Ltd 造血幹細胞の培養方法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084060A (en) * 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08205860A (ja) * 1994-01-21 1996-08-13 Usa Government 造血細胞の膨大化および移植方法
WO1996000777A1 (de) * 1994-06-30 1996-01-11 Boehringer Ingelheim International Gmbh Verfahren zur herstellung und züchtung hämatopoetischer vorläuferzellen
WO1997033978A1 (en) * 1996-03-12 1997-09-18 Life Technologies, Inc. Hematopoietic cell culture nutrient supplement
WO1998013475A1 (en) * 1996-09-25 1998-04-02 Academisch Ziekenhuis Leiden Methods for culturing cells
JPH10136978A (ja) * 1996-11-08 1998-05-26 Otsuka Pharmaceut Co Ltd 造血幹細胞の培養方法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515818A (ja) * 2004-10-07 2008-05-15 ステム セル セラピューティクス コーポレイション 妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激
WO2012133156A1 (ja) 2011-03-25 2012-10-04 国立大学法人京都大学 上皮系体性幹細胞の製造方法
US9249394B2 (en) 2011-03-25 2016-02-02 Kyoto University Method for producing epithelial stem cells
JP2014516562A (ja) * 2011-06-10 2014-07-17 コーニンクレッカ ネザーランド アカデミー ヴァン ウェテンシャッペン 幹細胞のための培養培地
JP2018085999A (ja) * 2011-06-10 2018-06-07 コーニンクレッカ ネザーランド アカデミー ヴァン ウェテンシャッペン 幹細胞のための培養培地
JP2021121214A (ja) * 2011-06-10 2021-08-26 コーニンクレッカ ネザーランド アカデミー ヴァン ウェテンシャッペン 幹細胞のための培養培地
JP7275196B2 (ja) 2011-06-10 2023-05-17 コーニンクレッカ ネザーランド アカデミー ヴァン ウェテンシャッペン 幹細胞のための培養培地

Also Published As

Publication number Publication date
WO2000075290A1 (fr) 2000-12-14
FR2794473B1 (fr) 2003-09-26
EP1181354A1 (fr) 2002-02-27
US7601534B1 (en) 2009-10-13
CA2375485A1 (fr) 2000-12-14
FR2794473A1 (fr) 2000-12-08
US20090325289A1 (en) 2009-12-31

Similar Documents

Publication Publication Date Title
US20090325289A1 (en) Process for the multiplication of stem cells
Petzer et al. Differential cytokine effects on primitive (CD34+ CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
EP2956538B1 (en) Bioengineered liver constructs and methods relating thereto
CN115261318B (zh) 产生自然杀伤细胞的方法
WO2009116893A1 (ru) Способ получения эндотелиальных клеток (варианты)
JP7748732B2 (ja) 肺細胞増殖および分化のためのシステムおよび方法
JP2002529073A (ja) 三次元装置における造血前駆細胞からのリンパ様組織特異的細胞の生成
CN109689858B (zh) 用于产生具有体内血管形成能力的中胚层和/或内皮集落形成细胞样细胞的方法
KR20040029311A (ko) 다능성 줄기 세포의 동종이식편의 내성화
CN117050941B (zh) 一种制备自然杀伤细胞的方法
US20050221482A1 (en) Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof
CN114621920A (zh) 一种由造血干祖细胞向nk细胞分化的方法及培养基
US9670460B2 (en) Method for using directing cells for specific stem/progenitor cell activation and differentiation
US20260085288A1 (en) Method of differentiation of pluripotent stem cells to hematopoietic precursor and stem cells
Rebel et al. Culture of purified stem cells from fetal liver results in loss of in vivo repopulating potential
JP2005527223A (ja) サイトカインフリーでの前駆細胞の増殖および維持
CN113667635A (zh) 无异源培养基及使用其扩增间充质干细胞的方法
CN115996732A (zh) 人专职性抗原提呈细胞的制造方法
CN106282089B (zh) 一种非人灵长类动物血管内皮祖细胞的高效扩增培养体系
US20230113074A1 (en) Derivation of hepatocytes and hematopoietic progenitors from human embryonic stem cells
WO2025188853A1 (en) Method of differentiation of pluripotent stem cells to natural killer cells
HK40121830A (zh) 多能干细胞向造血前体细胞和干细胞分化的方法
WO2024034656A1 (ja) 増殖性マクロファージ様細胞（ｐＭＡＣ）の製造方法
CN120641558A (zh) 细胞分化度的调节方法
CN118804970A (zh) 生长因子产生细胞及其制造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070410

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100525

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100813

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110802

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120110